Unresolved or Contradictory Issues About Management of Patients With Patent Foramen Ovale and Previous Cryptogenic Stroke: Additional Randomized Controlled Trials Are Eagerly Awaited - Test2 - elhamkhani - TriplyDB

Unresolved or Contradictory Issues About Management of Patients With Patent Foramen Ovale and Previous Cryptogenic Stroke: Additional Randomized Controlled Trials Are Eagerly Awaited

Unresolved or Contradictory Issues About Management of Patients With Patent Foramen Ovale and Previous Cryptogenic Stroke: Additional Randomized Controlled Trials Are Eagerly Awaited

http://www.wikidata.org/entity/Q26747769

about

Platypnea-orthodeoxia syndrome : Orthostatic dyspnea and possible pathophysiological substrates.Platypnea-Orthodeoxia Syndrome: Multiple Pathophysiological Interpretations of a Clinical Picture Primarily Consisting of Orthostatic Dyspnea.

P2860

Q38953089-AE64EE3B-BD5C-4917-8D09-A668EDE8DA7C Q38964637-BDADE1C8-96FF-4E58-B050-9EB8EA05E02E

P2860

Unresolved or Contradictory Issues About Management of Patients With Patent Foramen Ovale and Previous Cryptogenic Stroke: Additional Randomized Controlled Trials Are Eagerly Awaited

http://www.wikidata.org/entity/Q26747769

description

2016 nî lūn-bûn

@nan

2016 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Unresolved or Contradictory Is ...... led Trials Are Eagerly Awaited

@ast

Unresolved or Contradictory Is ...... led Trials Are Eagerly Awaited

@en

Unresolved or Contradictory Is ...... led Trials Are Eagerly Awaited

@nl

type

label

Unresolved or Contradictory Is ...... led Trials Are Eagerly Awaited

@ast

Unresolved or Contradictory Is ...... led Trials Are Eagerly Awaited

@en

Unresolved or Contradictory Is ...... led Trials Are Eagerly Awaited

@nl

prefLabel

Unresolved or Contradictory Is ...... led Trials Are Eagerly Awaited

@ast

Unresolved or Contradictory Is ...... led Trials Are Eagerly Awaited

@en

Unresolved or Contradictory Is ...... led Trials Are Eagerly Awaited

@nl

P1433

Q26747769-E759F653-952E-4D06-9A9C-D4F73CDAD74E

P1476

Q26747769-B3E11B7A-4566-494D-97CF-67B5858F3915

P2093

Q26747769-91E7FCD7-98E1-427E-85C8-FD0FE88D14E8

Q26747769-E21E15EE-45E7-492E-8D2A-DAFEAD6198D3

P2860

Q26747769-01FD5A72-77B4-4658-9B7A-C652A639DE5F

Q26747769-03613E97-67F7-416E-98C2-B90504B2BE42

Q26747769-11A38262-FB8D-4484-BA40-D482742B8501

Q26747769-1BE27D78-7FB1-43AD-B91E-2CA7DAE0B663

Q26747769-231FAF3B-D5A8-4A62-AB06-E725F958C4D0

Q26747769-39181B45-D9D4-4BF6-8B6B-F6D180113CFE

Q26747769-3E775B24-4FAB-4311-AE84-D3B697E26BDB

Q26747769-479B985B-8A3E-4DA5-9627-B443E3496FEF

Q26747769-4DAAA235-82DB-41B2-9C9E-51791476C581

Q26747769-6851BC7E-FC78-41A5-800B-C9E0BFCB5E18

P304

Q26747769-55DD595A-9947-46A8-BB7F-5E1D4C3B3435

P31

Q26747769-907FB7F0-C7AA-4DF8-A693-92749ECD3107

P3181

Q26747769-229A5ECF-BE46-4CB5-8AF2-DC73EDD1FD9D

P356

Q26747769-FE74BB70-FFBC-44F5-A6E3-F9D5F115A68F

P407

Q26747769-7EBB707D-CB13-4F9D-BCBA-F5DAA250798C

P433

Q26747769-E40246A5-8404-46F4-BBE9-C7F5A51D054F

P478

Q26747769-4CFF5FE0-2F91-4DD3-A786-012C9264F958

P577

Q26747769-CB844806-4E06-45C0-80C9-02BE9CEDD223

P698

Q26747769-C8235C18-BA30-418A-80E3-50858AD6E669

P932

Q26747769-4C9E10C5-C686-4308-858E-07756E78249C

P3181

P356

P1433

Journal of clinical medicine research

P1476

Unresolved or Contradictory Is ...... led Trials Are Eagerly Awaited

@en

P2093

Cesare Baldi

http://www.w3.org/2001/XMLSchema#string

Renato De Vecchis

http://www.w3.org/2001/XMLSchema#string

P2860

Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association

Closure versus medical therapy for preventing recurrent stroke in patients with patent foramen ovale and a history of cryptogenic stroke or transient ischemic attack

Patent foramen ovale transcatheter closure vs. medical therapy on recurrent vascular events: a systematic review and meta-analysis of randomized controlled trials

Patent foramen ovale: current pathology, pathophysiology, and clinical status

Device closure of patent foramen ovale versus medical therapy in cryptogenic stroke: a systematic review and meta-analysis.

Diagnosis of patent foramen ovale by transesophageal echocardiography and association with cerebral and peripheral embolic events.

Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts.

Closure or medical therapy for cryptogenic stroke with patent foramen ovale.

Is transcatheter closure better than medical therapy for cryptogenic stroke with patent foramen ovale? A meta-analysis of randomised trials.

Transcatheter patent foramen ovale closure versus medical therapy for cryptogenic stroke: a meta-analysis of randomized clinical trials.

P304

361-6

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3363514

http://www.w3.org/2001/XMLSchema#string

P356

10.14740/JOCMR2491W

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2016-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27081420

http://www.w3.org/2001/XMLSchema#string

P932

4817574

http://www.w3.org/2001/XMLSchema#string